72 related articles for article (PubMed ID: 9873664)
1. Rational design of a new series of mixed anti-HIV pronucleotides.
Schlienger N; Beltran T; Périgaud C; Lefebvre I; Pompon A; Aubertin AM; Gosselin G; Imbach JL
Bioorg Med Chem Lett; 1998 Nov; 8(21):3003-6. PubMed ID: 9873664
[TBL] [Abstract][Full Text] [Related]
2. Design of new mononucleotide prodrugs: aryl (SATE) phosphotriester derivatives.
Peyrottes S; Schlienger N; Beltran T; Lefebvre I; Pompon A; Gosselin G; Aubertin AM; Imbach JL; Périgaud C
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):315-21. PubMed ID: 11563043
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and study of a new series of phosphoramidate derivatives as mononucleotide prodrugs.
Egron D; Périgaud C; Gosselin G; Aubertin AM; Imbach JL
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):751-4. PubMed ID: 11563108
[TBL] [Abstract][Full Text] [Related]
4. Investigations of nucleoside H-phosphonamidate in the design of nucleotide prodrug.
Egron D; Imbach JL; Gosselin G; Aubertin AM; Périgaud C
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):895-7. PubMed ID: 14565305
[TBL] [Abstract][Full Text] [Related]
5. New insights regarding the potential of the pronucleotide approach in antiviral chemotherapy.
Gosselin G; Girardet JL; Périgaud C; Benzaria S; Lefebvre I; Schlienger N; Pompon A; Imbach JL
Acta Biochim Pol; 1996; 43(1):196-208. PubMed ID: 8790724
[TBL] [Abstract][Full Text] [Related]
6. A step further in the SATE mononucleotide prodrug approach.
Peyrottes S; Villard AL; Coussot G; Augustijns P; Lefebvre I; Aubertin AM; Gosselin G; Périgaud C
Nucleic Acids Symp Ser (Oxf); 2008; (52):539-40. PubMed ID: 18776492
[TBL] [Abstract][Full Text] [Related]
7. S-acyl-2-thioethyl aryl phosphotriester derivatives of AZT: synthesis, antiviral activity, and stability study.
Peyrottes S; Coussot G; Lefebvre I; Imbach JL; Gosselin G; Aubertin AM; Périgaud C
J Med Chem; 2003 Feb; 46(5):782-93. PubMed ID: 12593658
[TBL] [Abstract][Full Text] [Related]
8. S-Acyl-2-thioethyl aryl phosphotriester derivatives as mononucleotide prodrugs.
Schlienger N; Peyrottes S; Kassem T; Imbach JL; Gosselin G; Aubertin AM; Périgaud C
J Med Chem; 2000 Nov; 43(23):4570-4. PubMed ID: 11087582
[TBL] [Abstract][Full Text] [Related]
9. Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides.
Shirokova EA; Jasko MV; Khandazhinskaya AL; Ivanov AV; Yanvarev DV; Skoblov YS; Mitkevich VA; Bocharov EV; Pronyaeva TR; Fedyuk NV; Kukhanova MK; Pokrovsky AG
J Med Chem; 2004 Jul; 47(14):3606-14. PubMed ID: 15214788
[TBL] [Abstract][Full Text] [Related]
10. S-acyl-2-thioethyl phosphoramidate diester derivatives as mononucleotide prodrugs.
Egron D; Imbach JL; Gosselin G; Aubertin AM; Périgaud C
J Med Chem; 2003 Oct; 46(21):4564-71. PubMed ID: 14521418
[TBL] [Abstract][Full Text] [Related]
11. Aryl nucleoside H-phosphonates. Part 16: synthesis and anti-HIV-1 activity of di-aryl nucleoside phosphotriesters.
Romanowska J; Szymańska-Michalak A; Boryski J; Stawiński J; Kraszewski A; Loddo R; Sanna G; Collu G; Secci B; La Colla P
Bioorg Med Chem; 2009 May; 17(9):3489-98. PubMed ID: 19282192
[TBL] [Abstract][Full Text] [Related]
12. New series of mixed pronucleotides. Synthesis and anti-HIV activities of mononucleoside phenyl SATE phosphotriesters.
Schlienger N; Peyrottes S; Aubertin AM; Gosselin G; Imbach JL; Périgaud C
Nucleosides Nucleotides; 1999; 18(4-5):1025-6. PubMed ID: 10432735
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of zidovudine prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS.
Sriram D; Srichakravarthy N; Bal TR; Yogeeswari P
Biomed Pharmacother; 2005 Sep; 59(8):452-5. PubMed ID: 16154314
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, anti-HIV activity, and stability studies of 5'-phosphorofluoridate derivatives of AZT.
Egron D; Arzumanov AA; Dyatkina NB; Aubertin AM; Imbach JL; Gosselin G; Krayevsky A; Périgaud C
Bioorg Chem; 2001 Dec; 29(6):333-44. PubMed ID: 11846432
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine.
Saboulard D; Naesens L; Cahard D; Salgado A; Pathirana R; Velazquez S; McGuigan C; De Clercq E; Balzarini J
Mol Pharmacol; 1999 Oct; 56(4):693-704. PubMed ID: 10496951
[TBL] [Abstract][Full Text] [Related]
16. Diastereoselective synthesis of cyclosaligenyl-nucleosyl-phosphotriesters.
Rios Morales EH; Balzarini J; Meier C
Chemistry; 2011 Feb; 17(5):1649-59. PubMed ID: 21268168
[TBL] [Abstract][Full Text] [Related]
17. Anti-HIV pronucleotides: decomposition pathways and correlation with biological activities.
Egron D; Lefebvre I; Périgaud C; Beltran T; Pompon A; Gosselin G; Aubertin AM; Imbach JL
Bioorg Med Chem Lett; 1998 May; 8(9):1045-50. PubMed ID: 9871705
[TBL] [Abstract][Full Text] [Related]
18. Lipophilic phosphoramidates as antiviral pronucleotides.
Zemlicka J
Biochim Biophys Acta; 2002 Jul; 1587(2-3):276-86. PubMed ID: 12084469
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro anti-human immunodeficiency virus structure-activity relationships and biological stability of 5'-O-myristoyl analogue derivatives of 3'-azido-2',3'-dideoxythymidine (AZT) as potential prodrugs.
Parang K; Wiebe LI; Knaus EE
Antivir Chem Chemother; 1998 Jul; 9(4):311-23. PubMed ID: 9875410
[TBL] [Abstract][Full Text] [Related]
20. cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system.
Meier C; Knispel T; De Clercq E; Balzarini J
J Med Chem; 1999 May; 42(9):1604-14. PubMed ID: 10229629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
